The 2009 edition of the NOAH Compendium Data Sheets for Animal Medicines is now being dispatched, free of charge, to each practice premises.
Meanwhile, the online version of the compendium (www.noahcompendium.co.uk), launched 3 years ago to provide a free and convenient source of information about animal medicines for both prescribers and consumers, has just had its 9 millionth page view. The site gets about 3000 visits a day.
Whilst it is possible to order additional print copies of the compendium, NOAH points out that the online version has the beauty of being updated every week with new products, indications and other data. Plus the site is searchable by active ingredient, species, therapeutic indication or text search.
NOAH chief executive Phil Sketchley said: "We try to make the online Compendium as useful and as quick and easy to use as it can be, and while we have received overwhelmingly positive feedback we are always interested to hear how you think it could work better for you, so we can keep this in mind for any future improvements".
Fort Dodge Animal Health has announced that its Duvaxyn WNV vaccine against West Nile Virus (WNV) is now available in the UK, following its licensing through the European Medicines Agency (EMEA).
Duvaxyn WNV is the first vaccine available in Europe to protect horses against this emerging disease threat. 288 horses and two people in Italy were found to be infected with WNV during the outbreak that hit northern Italy in late 2008 where it is now considered endemic. The disease is endemic in all areas of North America where it has claimed the lives of both horses and humans.
West Nile Virus is caused by a highly contagious flavivirus, which is transmitted by mosquitoes, primarily of the Culex species. The natural hosts of West Nile virus are birds, with migratory birds from Africa carrying the disease. Mosquitoes become infected after taking a blood meal from infected birds and then may transmit the disease to horses and even humans. While horses are 'dead end hosts,' the consequences can be severe as the virus causes encephalitis or meningitis. Mortality rates among horses which develop neurological signs are high and there is no palliative cure for the disease. Treatment is limited to symptomatic relief which can be long and expensive.
Sabrina Jordan, UK Business Manager for Equine Vaccines at Fort Dodge said: "WNV is an increasing threat to the equestrian sector in the UK and is a particular challenge for owners who transport their horses around the world.
"The fact that a vaccine is now available will undoubtedly offer peace of mind to the equestrian community. They can be reassured that horses in the UK can now be vaccinated against WNV with a vaccine that has already been shown to be highly effective in protecting horses in America.
"With any vaccine, a record that a horse has been vaccinated with Duvaxyn WNV should be recorded in its horse passport. By presenting this vaccine in pre-filled syringes with Infovax-ID labels, we've aimed to make both the administration and record keeping of Duvaxyn WNV as convenient as possible.
"To build understanding of this potentially fatal disease threat, we are continuing to work with governments and authorities at a national and European level, as well as working in partnership with the UK's veterinary community to ensure that owners are fully informed about the risk WNV poses and of the benefits of vaccination."
Seven graduands from The University of Nottingham's School of Veterinary Medicine and Science have become the first from the new school to become members of the Royal College of Veterinary Surgeons.
Nottingham is the first new veterinary school in the UK for over 50 years, and the process to recognise its degree for the purposes of RCVS membership is currently in its final stages. Following a visitation and audit process, RCVS Council unanimously recommended the degree's approval to the Privy Council, where the final decision lies.
Generally, veterinary graduates become RCVS members - which they need to be in order to practise in the UK - at a ceremony on the day of their graduation. However, sometimes they wish to start work before graduation and can therefore apply to register as graduands, as in this case.
Although formal Privy Council approval of the Nottingham degree is still awaited, RCVS external examiners have overseen the School's final exams during the last year of the course to ensure that they meet the required standards.
The Nottingham graduation ceremony will take place on 22 July, when a further 77 students will graduate, and those wishing to practise in the UK will become members of the College.
The RCVS 2010 Survey of the Veterinary and Veterinary Nursing Professions indicated that, on average, new graduates took one month to find work on graduating, with 63% going straight into clinical practice.
In the series of 9 short videos, BCF's in-house vet, Kimberly Palgrave, demonstrates how to perform a basic abdominal ultrasound examination in small animal patients.
The videos, which were produced in collaboration with The Royal (Dick) School of Veterinary Studies, also cover how to alter the controls on your ultrasound machine to get the most of your equipment.
Kimberly said: "I am really passionate about encouraging as many vets using ultrasound in their daily routine as a diagnostic tool. My aim for these videos is to give vets in practice a resource to develop their ultrasound skills. We hope you enjoy the videos and we are already busy developing further videos."
To see the videos visit the ultrasound gallery.
www.bcftechnology.com / www.facebook.com/bcftechnology.
The RCVS has published the conclusions of The McKelvey Report, a review into the circumstances leading to a substantial overspend on the College's new database and development works at Belgravia House.
The review was carried out by Professor Bill McKelvey - a member of the College's Governance Review Group - and two of the College's Privy Council-appointed Council members to consider all aspects relating to the College's budgeting and expenditure process, and propose lessons that could be learned.
Whilst the full report has not yet been published, its conclusions highlight:
Overall, the report concluded that:
Weaknesses exist in the governance of the RCVS which pose significant risks to the proper conduct of its business. Executive staff have not been provided with a robust governance framework by the Council, and this has led to a number of unnecessary misunderstandings between Executive staff and Non Executive members of Council. These matters should be urgently addressed by Council in order to ensure that the confidence of ordinary members of the profession in their College can be restored.
Dr Jerry Davies, RCVS President said: "That such a review was required is regretted, but I would like to thank Professor McKelvey, Richard Davis and Judith Webb for their diligence in this work. Their recommendations will be a very helpful addition to the work that is currently underway to ensure corporate governance is fit for purpose and, in particular, that the management of capital projects within the College is optimised."
The full report is available here.
Animalcare Ltd has launched Marbocare (marbofloxacin) 100mg/ml solution for injection, a third-generation fluoroquinolone for the treatment of E.coli mastitis and bovine respiratory disease (BRD) in cattle, and Metritis Mastitis Agalactia in pigs.
The company highlights the product's unique flexible dosage regimen of once daily injections for 3 days against E.coli mastitis and BRD, plus a single intramuscular (IM) high dose (8mg/100kg) for BRD.
Animalcare says this regimen, coupled with the flexibility of administration afforded by all three injection routes (intravenous IV, subcutaneous SC and IM), a low volume dose and good syringeability, all combine to offer ease of use; resulting in a reduction in handling and less stress for the cattle.
Developed for veterinary use only, Marbocare has broad spectrum activity against Gram+ve and Gram-ve pathogens. Animalcare says the product is especially effective against E.coli mastitis and the key bacterial pathogens associated with BRD, as well as M.bovis.
Marbocare has milk withdrawal times of 36 hours after the last treatment following the 3 day course and 72 hours after a single shot for BRD. Meat withdrawal is 6 days after multiple injections and 3 days after the single shot.
Marbofloxacin has proven efficacy in a comparative international, multi-centre, controlled, randomised field trial1 in 62 dairy cows with E.coli mastitis. Marbofloxacin cure rates were significantly higher than the control product. In respiratory disease it showed a more rapid clinical response in comparison to tilmicosin2, ceftiofur3 and oxytetracycline4. Marbofloxacin was shown to be well tolerated, leading to a fast return to appetite, liveweight gain and associated welfare benefits.
Marbocare is also licensed in the treatment of Metritis Mastitis Agalactia syndrome in pigs, given by IM injection, with a 4 day meat withdrawal.
Tony Liepman, Product Manager from Animalcare said: "Marbocare is competitively priced whether used on its own or alongside a single-dose anti-inflammatory such as Emdocam (meloxicam)."
Marbocare is a POM-V licensed product presented in 50 and 100ml multi-dose vials.
References
Feel Good Colic Rectals is a 20-minute online guide that uses state-of-the-art 3D modelling technology to allow you to visualise an examination of the normal equine abdomen, and to demonstrate how to differentiate abdominal abnormalities during a rectal examination.
The video features leading colic experts Professor Debra Archer BVMS PhD CertES (Soft Tissue) DipECVS MRCVS, head of equine surgery at the University of Liverpool, and Rachael Conwell BVetMed CertEM(IntMed) DECEIM MRCVS, European specialist in equine internal medicine.
To be in with a chance of winning one of 30 rectal tops, watch Feel Good Colic Rectals at www.boehringer-academy.co.uk, then answer two multiple choice questions.
The new hospital, which is led by a large team of internationally-renowned Specialists, supported by residents, interns and registered veterinary nurses, will over time employ over 100 veterinary professionals.
CVS says the site will offer the latest technology and treatments in all small animal disciplines including: general surgery, orthopaedics, neurology and neurosurgery, internal medicine, ophthalmology, cardiology, dermatology, oncology and dentistry, as well as dedicated anaesthesia, analgesia, diagnostic imaging and intensive care departments.
There will be a multi-disciplinary approach, with a team around every patient, to ensure the best outcome for the animal.
CVS says BVS's oncology department, with its stereotactic linear accelerator for radiotherapy, will offer most advanced cancer treatment for cats and dogs in Europe.
The site also has the latest CT and MRI scanners and a separate feline unit.
On arrival, clients are taken to a special customer experience zone by a dedicated client liaison officer to ensure their pet is comfortable and they are fully informed about their procedure.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our advanced facilities and eminent colleagues will mean we can provide the best animal care to pet owners across the South West, and we have invested in cutting-edge technology to bring cancer treatment in pets to the next level.
"So we know that this site will become as a centre of excellence in the veterinary world.”
https://www.bristolvetspecialists.co.uk
The study titled “Diagnosis and treatment of gastro-oesophageal junction abnormalities in dogs with brachycephalic syndrome” included thirty-six client-owned brachycephalic dogs (French bulldogs, pug and English bulldogs) in a prospective, randomised trial.
Antacid treatment (omeprazole (1mg/kg PO q24 hours) and magaldrate (5-10mL/dog PO q8-12 hours)) was randomly prescribed in 18 dogs before and after surgery, while the other 18 dogs did not receive any gastrointestinal medical treatment.
Digestive clinical signs and gastro-oesophageal junction abnormalities (GJA) were assessed and scored at presentation, at the time of surgery and at recheck. GJA were assessed during endoscopy in standard conditions, as well as during endotracheal tube obstruction. All endoscopic procedures were recorded and reviewed by a single, blinded reviewer.
In order to assess whether endotracheal tube obstruction manoeuvre accurately detects GJA, the procedure was also performed during the examination of the gastro-oesophageal junction in a group of 10 control dogs. Control dogs were healthy or had diseases that were not expected to interfere with gastro-oesophageal junction dynamics, and were anaesthetised for independent purposes.
Dr Emilie Vangrinsven, corresponding author for the paper said: "Although results of multivariate analysis failed to demonstrate a direct effect of antacid treatment, a significant interaction between antacid treatment status and improvement of digestive clinical score throughout the endoscopies was present, meaning that treated animals seem to improve faster and have lower clinical scores after surgery than untreated animals. Furthermore, a significant improvement in GJA-obstruction score was present in the treatment group only.
"In contrast to standard endoscopy, the obstruction manoeuvre during endoscopy allowed detection of GJA in dogs, even in the absence of clinical signs. We were concerned that the obstruction manoeuvre may induce false positive results for the diagnosis of dynamic GJA; in the control group, GJA during obstruction manoeuvre were found to be negligible suggesting that this technique does not significantly overestimate the presence of GJA.”
Nicola Di Girolamo, Editor of JSAP said: "Based on this study, antacid treatment administered to brachycephalic dogs undergoing surgery may be beneficial. It should be noted that a direct influence of antacid treatment on digestive clinical and lesion scores could not be significantly demonstrated, which may have been because of the lack of an actual difference, or as a result of the small sample size.”
The full article can be found in the March issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13279
Reference
Photo: Professor Ian Ramsey
VetYogi’s new ‘VetYogi Collective’ offers an on-demand online hub of yoga, mental health and wellbeing sessions designed to meet the individual needs of vets, RVNs, practice managers, receptionists, students and paraprofessionals.
Subscription includes a monthly live yoga session and access to a library of content which includes yoga sessions lasting from minutes to over an hour.
There are also videos, and advice on guided meditation to help support wellbeing and manage stress.
Chloe says: “It’s important that everyone who has a need, has access to the type of wellbeing tools that they respond best to, so we have developed self-care sessions for all roles in the profession.
"If you have had a hard day or a stiff neck from working in theatre for hours, or are just feeling tense and unable to switch off, you need help there and then.
"The VetYogi Collective provides that support around the clock which we simply couldn’t deliver any other way.”
Individual subscriptions cost £12 per month.
Practices signing up their team are offered preferential rates and can use the VetYogi Collective badge on their materials to signal their commitment to supporting wellbeing.
collective.vetyogi.com
The Veterinary Wound Healing Association (VWHA) has become the third veterinary association to make a new home on VetSurgeon.org.
VWHA President Jacintha Wilmink said: "We're very excited about joining VetSurgeon.org and how it will allow our members to connect with each other and share information quicker and more easily than ever before".
In common with the other associations, the VWHA is making its content available for all VetSurgeon members to access, however only VWHA members can submit cases to its section for discussion, or participate in the VWHA forum. Jacintha added: "We hope that the cases and discussions in our section of the site will be of value to all practitioners, and that many more of you will want to join the association and participate".
Information about the benefits of joining the VWHA is available here.
Zoetis has announced the launch of Apoquel (oclacitinib maleate), a new treatment for pruritus associated with canine allergic dermatitis and the clinical manifestations of atopic dermatitis.
Uniquely, the new treatment inhibits the JAK enzyme, a protein that is integral to the signalling pathway of cytokines that are pro-inflammatory or have a role in allergic and itch response.
According to the company, pruritus affects about one in six dogs whose owners seek veterinary help, and about half of all itchy dogs will have an underlying allergic skin condition for which the new product would be indicated.
Zoetis says that because Apoquel targets the specific pathways of pruritus (itch) and inflammation, it is less likely to cause unwanted side effects than glucocorticoids and demonstrates anti-pruritic efficacy within four hours.
Pascal Prélaud, a dermatology specialist from Paris, who took part in the clinical development programme of Apoquel, said: "When a dog develops an itch related to an allergy, it can be life-disrupting for the dog and the entire family. I've learned firsthand the fundamental difference this treatment can make to a dog and its owners in stopping the itch, but without many of the side-effects that are common with steroids.
Zoetis reports that in clinical trials, Apoquel demonstrated a good safety profile and efficacy for the treatment of pruritus and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners within 24 hours of administration, and pruritus continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinarians were significantly improved after one week and continued to improve long term during the studies (four months).
Apoquel is a POM. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium- to long-term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
The Crafty Vet Project aims to ignite your interest in one of a range of creative hobbies, which include cheese, beer, candle, soap and teddy-bear making, with kits available for sale from the new 'Craft Corner' section of their website. £3 from the sale of each kit will go to Vetlife.
Sarah said: "We wanted other veterinary professionals to experience the same pleasure that we get from creative hobbies. It is a chance for people no matter what day you have had to switch off, follow a pattern or instructions and come out with something at the end that you can be truly proud of."
Your new hobby might even turn into a nice sideline business. Sarah said: "One evening over a catch-up Zoe and I were discussing items that we wished we had in practice to make our lives as nurses easier.
"Despite having drunk 2 bottles of wine together we felt that there and then was the best time to start our new business. Two hours later having chopped up an old pair of curtains, accidently sewn my jumper sleeve into the material and woken my husband up at 3am to our cackles, we had the first prototype of our Slumberpet Recovery Coat.
"Our business has grown nicely since then and we are still coming up with more ideas, albeit in a slightly more sober, professional manner."
To select and order your hobby kit, visit: https://www.vnpetproducts.co.uk/craft-corner
The nomination period runs until 5pm on Tuesday 31 January 2018. In order to stand, candidates will need to submit a nomination form along with contact details, a short biography and a statement, and supply a high-resolution digital photograph.
Each candidate also needs two nominators, who should be veterinary surgeons who are on the College’s Register but are not current RCVS Council members.
Professor Stephen May, RCVS President, said: "I myself have been an elected Council member since 2012, and it has given me tremendous opportunity to get involved with a whole range of subjects, including my particular interests, undergraduate education and lifelong learning. It’s incredibly rewarding to see how the decisions you make during your time on Council can really benefit the profession, and I would encourage anyone who shares an interest in the future of our profession, whether that be about graduate outcomes, practice standards, the wider veterinary team or the effects of Brexit, for example, to stand for election."
Although the RCVS is planning the elections as usual, it is concurrently preparing for a change to its governance arrangements, including a reduction in the size of the Council, as agreed in March 2016.
Commenting on the Legislative Reform Order (LRO) that will be required to amend the Veterinary Surgeons Act 1966, RCVS Registrar Eleanor Ferguson said: "This is a complex matter and, unfortunately, due to unavoidable delays associated with the 2017 General Election and the impact of preparing for the UK’s departure from the European Union, the LRO has not yet completed the legislative process.
"This means that whilst we will be running the elections on the basis that there will be six elected places available, as per the old size and structure, it should be expected that under the new size and structure, only three places will ultimately be available."
Meanwhile, due to comparable changes to the governance of the Veterinary Nurses Council, including a reduction in its number, there will be no 2018 VN Council elections as the outgoing members will not need to be replaced.
The RCVS Council election period will start around mid-March and voting will close at 5pm on Friday 27 April 2018.
Nomination forms, guidance notes and frequently asked questions are available for prospective RCVS Council candidates at www.rcvs.org.uk/rcvscouncil18.
The mandatory regulation of veterinary practices, including statutory powers of entry and inspection, is one of the main parts of the College's proposals for new primary legislation that would replace the current Veterinary Surgeons Act 1966.
The working group, which is expected to present the details of a Mandatory Practice Regulation system to Council by the end of 2024, will be chaired by RCVS President Sue Paterson FRCVS.
It will include Standards Committee Chair Linda Belton MRCVS and Practice Standards Group Chair Belinda Andrews-Jones RVN, alongside veterinary, veterinary nursing, lay and external representatives.
Sue said: “With over 70% of practice premises currently under its ambit, our Practice Standards Scheme (PSS) has shown how keen practices are to maintain high standards.
"However, it is a voluntary scheme and, as a result, there is no mechanism to ensure standards across all practices, or to ensure change in those rare situations where it is needed.
“At present, the RCVS only regulates individual veterinary surgeons and nurses, and the veterinary sector does not have an equivalent to the Care Quality Commission, which considers human healthcare premises.
"This means that the onus for maintaining standards within the workplace falls on regulated individuals rather than the business structure.
"We will consider what a scheme that puts more statutory responsibility on business owners to maintain standards should look like.
“I look forward to working with colleagues in RCVS Council, VN Council and other veterinary organisations via this group to really flesh out what this regulatory system might look like in the future, to make sure it is appropriate, robust, proportionate and enforceable.
"Establishing these details will also prove invaluable in our lobbying work with government, ministers and MPs.”
Novartis Animal Health has launched a chewable formulation of Milbemax wormer, for dogs.
According to the company, clinical studies have shown that the chicken-flavoured formulation and chewy texture of Milbemax Chewable Tablets is highly palatable, with more than 94% of dogs showing spontaneous acceptance from hand. Novartis says this should help make worming simpler and improve compliance, something which is particularly important given market research which shows that difficulties in administering medications often leads to missed treatments.
Containing milbemycin oxime and praziquantel, the new tablets deliver the same broad spectrum efficacy as existing Milbemax formulations, effective for the treatment of roundworm, hookworm, whipworm, lungworm and tapeworm, and for the prevention of heartworm.
Folkert Kamphuis, Chief Operating Officer at Novartis Animal Health said: "The new EASYCHEW™ formulation represents Novartis Animal Health's latest innovation. It will make worming a treat whilst providing tried-and-trusted Milbemax efficacy. With Milbemax chewable tablets we give pet owners a wormer that is easy to administer and veterinarians the trusted efficacy of Milbemax."
Milbemax Chewable Tablets are available for both dogs and puppies, in four and forty-eight tablet packs.
Petplan is calling for nominations for this year's 'Petplan Pet Insurance Advisor Award'.
The award is to recognise the hard work and dedication that Pet Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially. You can nominate a PIA at your practice by visiting www.petplan.co.uk/pia. The winner will receive a new laptop and their practice will receive £100 in vouchers.
Petplan Marketing Manager Alison Andrew said: "At Petplan we are proud to recognise the dedication and hard work that Pet Insurance Advisors put in to give their customers informed and up-to-date advice. So please get your nominations in!"
Nominations close on 3rd September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress on 9th October.
A new study, led by academics at the University of Bristol's School of Veterinary Sciences and published online in Applied Animal Behaviour Science, has investigated the occurrence of dog aggression towards people with a survey of UK dog owners.
Nearly 15,000 questionnaires were distributed to dog owners of which 4,000 were returned and used in the analysis.
The researchers found that:
The study highlighted that the majority of dogs showing aggression do so in just one of these situations. Researchers say this indicates that the common tendency to categorise dogs as either generally 'safe' or 'vicious' is a misconception, and that most dogs show aggression as a learnt response to particular situations.
Dr Rachel Casey, Senior Lecturer in Companion Animal Behaviour and Welfare, said: "Dog owners and members of the public need to be aware that any dog could potentially show aggression if it is anxious or feels threatened, even when it has never done so before.
"On the other hand, dogs which have shown aggressive signs in one situation are not necessarily 'dangerous' when in other contexts - an important consideration in the assessment of animals, such as in rehoming centres."
The study also compared the characteristics of those dogs reported to show aggression with those which had never done so. It was revealed that factors such as training classes attended, type of training method used, the sex and neuter status of dogs, the age category of owners, and the breed of dogs were all associated with the occurrence of aggression.
Different risk factors were found to be significant in statistical models examining aggression to family members and unfamiliar people. This suggests that different factors are important in the development of aggressive signs depending on the situation.
The research also highlighted that although general characteristics, such as breed type, are significant risk factors across large populations they explain only a small amount of the overall difference between aggressive and non-aggressive dogs. This suggests that it is not appropriate to evaluate the risk of aggressive behaviour in an individual dog using characteristics such as breed type.
Human directed aggression in domestic dogs (Canis familiaris): occurrence in different contexts and risk factors, Rachel A. Casey, Bethany Loftus, Christine Bolster, Gemma J. Richards, Emily J. Blackwell, Applied Animal Behaviour Science, published online 11 December 2013.
Veterinary Insights has announced that it will be unveiling Vet Viewer, its new veterinary benchmarking service, at the SPVS/VPMA event at the Celtic Manor Resort, Newport, South Wales on January 22-24.
As those familiar with the old Fort Dodge Indices will be aware, benchmarking services like these allow participating veterinary practices to compare their own activity and business results against a broad panel of similar veterinary practices so that they can better gauge their own market performance and make changes to their working practices as they see fit.
Vet Viewer is provided free of charge to participating vet practices. It delivers monthly information to help practices get a quick understanding of key business metrics and a clear view of practice activities and the income they are generating.
Veterinary Insights' Managing Director Alexander Arpino said: "The Benchmarking Service has been carefully designed to give practical business support to veterinarians and we have had a great response from the 100 plus clinics that have signed up to the service to date. We have plans to expand the range of services offered to enable an even wider range of meaningful data and KPIs for veterinarians to manage their businesses."
The incoming President of the Society of Practising Veterinary Surgeons (SPVS), Nick Stuart said: "We have been working closely with Veterinary Insights for over a year on this valuable service and we are delighted to say that SPVS members will have access to additional features that track practice profitability and other important financial measurements."
For further information contact Veterinary Insights on 01403 800135 or visit: www.vetviewer.co.uk
Additionally you can download a detailed brochure on the Benchmarking Service here: http://www.vetviewer.co.uk/downloads/vet-viewer-brochure.pdf
The full eligibility criteria, including FAQs and guidance notes, for veterinary surgeons who wish to stand for RCVS Council can be found at: www.rcvs.org.uk/rcvscouncil21. The deadline for nominations is 5pm on Sunday 31 January 2021.
Due to the ongoing postal problems caused by the coronavirus pandemic, RCVS Council has approved a temporary change to the RCVS Election Scheme this year to allow nominations to be submitted electronically, rather than in hard copy. This temporary change is currently before the Privy Council for final approval.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the elections, said: "For prospective RCVS and VN Councils election candidates this will mean that, rather than having to send us hard copies of your nomination documents in the post, these can simply be emailed to the College along with the relevant digital photographs and electronic signatures."
The College has also updated its information and guidance for prospective candidates, including an informal ‘job description’, to help them better understand what it means to be members of RCVS Council, their responsibilities, commitments and how they help the College meet its strategic goals, as well as the principles and rules governing their conduct.
Prospective candidates for RCVS Council can also contact RCVS President Dr Mandisa Greene for an informal conversation on what it means to be a Council member on president@rcvs.org.uk.
Mandisa said: “As I have often said publicly, when I decided to stand for RCVS Council it was out of a mixture of fear and curiosity, the RCVS seemed liked some distant organisation that was often talked about, but not entirely understood, and that made me want to find out more. It is fair to say that, since joining RCVS Council, I have learned and experienced a great deal, have got to know people in our profession that I would otherwise never have had the opportunity to meet, and have been at the forefront of key discussions about how our profession is regulated and its future.
"Throughout my time on Council I have also been a working mother of two young children and so, for those who are concerned about how being a Council member can fit around personal and professional life, I can assure you that there is flexibility that allows you to carry out your Council work around other commitments.
"I do hope that, if you are interested in the future of our professions and having a say in our professional and educational standards and how we are governed, then please take the time to consider becoming a member of RCVS Council and don’t hesitate to get in touch with me if you want to know anything more."
There is one more Council meeting before the nomination period ends. It will take place online on Thursday 21st January 2021 and prospective candidates who would like to get a feel for it are welcome to attend as observers: contact Dawn Wiggins, RCVS Council Secretary, on d.wiggins@rcvs.org.uk.
RCVS Knowledge launched the Canine Cruciate Registry on the Amplitude pro registry platform last year.
The automated registry, the first of its kind in veterinary medicine, allows the profession to evaluate the success of surgical techniques, and practitioners to benchmark their performance.
In June, RCVS Knowledge had a poster detailing the purpose, impact and aspirations of the registry accepted at the PROMs research conference, which before now typically only accepted submissions from the field of human medicine.
This, says Amplitude, marks the first step in sharing information about running registries designed to identify best practice in the care and treatment of both animals and people.
Chris Gush, Executive Director of RCVS Knowledge, said: "RCVS Knowledge is proud to be leading the development of clinical audit and registries to support the veterinary professions on their journey to continually improve the care they deliver.
"Registries are key in supporting the professions in understanding first-hand information about our patients with certain conditions, both individually and as a group, contextualizing with information from their owners, and over time, to increase our understanding of that condition.”
Five graduates from St George's University School of Veterinary Medicine (SGUSVM), in the Caribbean island of Grenada, have passed the Statutory Membership Examination of the UK's Royal College of Veterinary Surgeons.
According to the University, SGUSVM graduates have traditionally demonstrated impressive pass rates on this rigorous exam, but this year's 100% pass rate by SGU students - compared with an overall 44% pass rate for candidates overall - is an exceptional result for SGU students, and only the second time it has been achieved in the school's history.
In order to practice veterinary surgery in the UK, all graduates with foreign or Commonwealth qualifications must pass the RCVS examination. The exam consists of two days of written papers, followed by clinical, oral and practical exams at a UK veterinary medical school. Thirty-five St George's graduates have passed into the RCVS since the School's inception in 1999.
The RCVS sets no quota for this Statutory Membership Examination, meaning those who meet the standards will pass, regardless of the number of candidates sitting the exam.
Austin Kirwan, St George's Associate Dean of UK and Ireland Clinical Affairs stated: "St George's School of Veterinary Medicine once again produces an excellent set of results with a 100 percent pass rate for the Royal College of Veterinary Surgeons Statutory Membership Examination for those SGU students who sat the examination. This is a credit to the school in the quality of education it provides, but also an indication of the calibre of person SGU attracts in its student cohort - outstanding success abounds by thinking beyond."
Presenting the graduates with a membership certificate at the Ceremony of Admissions at Belgravia House in London, RCVS President Dr Jerry Davies said: "I was delighted to welcome so many of this year's successful candidates to the College. Whether newly graduated or long qualified elsewhere, all of those registering today have succeeded in meeting the educational and professional requirements that enable them to call themselves veterinary surgeons and to practise in the UK."
The half day meeting will take place on Tuesday 25th May from midday to 4pm BST.
Speakers at the event, which accounts for four hours’ CPD, include: Dr Andy Sparkes, feline medicine specialist; Professor Patrick Pageat, president of IRSEA Group; Dr Nathalie Dowgray, head of ISFM and cat behaviourist, Susanne Hellman Holmström.
The programme is as follows:
There will also be a round table discussion on how to raise the focus on cats, when delegates will have the chance to interact with the speakers.
Abigail King, senior behaviour product manager at Ceva Animal Health, said: “The Ceva Cat Expertise 2021 event is designed for the whole veterinary team and will provide online delegates with comprehensive and up-to-date information on feline hypertension and behaviour, including hands on tips which can be incorporated into day-to-day work in practice, as well as an overview of feline opportunities and trends for the future.”
All delegates will receive a diploma of participation and the meeting will be available on demand after the live event to all registered participants until 1 September 2021.
To register for Ceva Cat Expertise 2021 online event visit https://ceva-cat-expertise-2021.confetti.events/, contact your local Ceva Animal Health account manager or email cevauk@ceva.com.
In its updated position statement, the association emphasises its support of current UK legislation and says it would like to see improved implementation of current laws, in particular when informed by an evidence-based welfare outcomes approach.
The BVA also recommends that any proposals to improve welfare during transport should embrace all forms of transport and include welfare issues before, during and after movement. This, it says, would help ensure that a well-defined set of animal welfare standards are met for the entirety of any journey.
The BVA recommends that animals are slaughtered as close to the point of production as possible and supports the exploration of further opportunities which would assist this. It recognises that transportation of live animals can be unavoidable in some situations – for example, journeys between the Scottish Islands and Highlands – but says that no animal should be exported to a destination with unknown welfare standards, to one using systems currently banned in the UK or to a country where it would be slaughtered without stunning.
BVA President Simon Doherty said: "Any kind of movement has the potential to impact on an animal’s health and welfare. Ideally, we’d like to see livestock slaughtered close to the point of production, as long as all legislative health and welfare standards can be maintained. However, we recognise the high standards of welfare in the UK and support better implementation of current legislation.
"We have taken care to reiterate that any improvements made to live animal transport should consider welfare issues before, during and after movement so that a more complete approach is taken on this issue.
"We recognise that journey length is not the only influencer of welfare conditions for animals, and transport needs to be looked at as a whole rather than focusing on single factors. The most important thing for Government to do is to consider the evidence base when it weighs up options for making improvements."
Andra-Elena Enache and Savina Gogova join the head of service Richard Everson, an RCVS and European Recognised Specialist, to form one of the strongest ophthalmology teams in the UK.
Richard said: “It is fabulous that Andra and Savina were both successful in their specialist examinations.
“Of course, we already knew their expertise but passing the examination requires not just an unparalleled knowledge of their subject but also the constitution that allows them to prove their knowledge, skills and professionalism in the crucible of the examination environment.
“For both Andra and Savina to pass at the first time of asking is remarkable and just confirms their brilliance. It’s also a big boost for NDSR.
“Having three internationally-recognised specialists in ophthalmology in one hospital makes the service so much more resilient; for example, we will never have to close due to annual leave or lecturing commitments.
“This strength in depth means we really can offer the best possible service to our referring vets and poorly pets.”
For more information, visit: www.ndsr.co.uk.